KROS Keros Therapeutics Inc.
FDA Catalyst Company
46.23
+2.15 (+5%)
Previous Close
44.07
Open
45.47
52 Week Low
28.5
52 Week High
68.29
Market Cap
$1,111,014,362
Shares
24,034,924
Float
13,152,345
Enterprise Value
$829,594,306
Volume
16,579
Av. Daily Volume
137,543
Live cash est
$88,666,444,222
Cash Burn
N/A
No. Mths Cash
12
Insiders %
0.2
Total debt to equity
4.35
Earnings Date
01/01/2001
EPS EST.
1.82
EPS PRIOR.
1.82
EPS
1.82
Rev guidance
$10,459,000,000
Biotech Analyst Ratings
Analyst | Action | Rating Now | PT Prior | PT Now | Last Updated |
---|---|---|---|---|---|
SVB Leerink | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 12/08/2020 |
HC Wainwright & Co. | Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 30 day FREE TRIAL. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien. | 12/08/2020 |